Abstract There have been many studies examining HIVinfection-related alterations of magnetic resonance imaging (MRI) diffusion metrics. However, examining scalar diffusion metrics ignores the orientation aspect of diffusion imaging, which can be captured with tractography. We examined five different tractography metrics obtained from global tractography maps (global tractography FA, average tube length, normalized number of streamtubes, normalized weighted streamtube length, and normalized total number of tubes generated) for differences between HIV positive and negative patients and the association between the metrics and clinical variables of disease severity. We also examined the relationship between these metrics and cognitive performance across a wide range of cognitive domains for the HIV positive and negative patient groups separately. The results demonstrated a significant difference between the groups for global tractography FA (t=2.13, p= 0.04), but not for any of the other tractography metrics examined (p-value range=0.39 to 0.95). There were also several significant associations between the tractography metrics and cognitive performance (i.e., tapping rates, switching 1 and 2, verbal interference, mazes; r≥0.42) for HIV infected patients. In particular, associations were noted between tractography metrics, speed of processing, fine motor control/speed, and executive function for the HIVinfected patients. These findings suggest that tractography metrics capture clinically relevant information regarding cognitive performance among HIV infected patients and suggests the importance of subtle white matter changes in examining cognitive performance.
Introduction
We know that the human immunodeficiency virus (HIV) penetrates the central nervous system (CNS) within 2 weeks of initial infection (Davis et al. 1992) . Once in the CNS, HIV instigates a cascade of immunological response typically characterized by inflammation and the release of cytokines Bell 2004) . The prolonged or chronic release of these chemicals results in CNS injury with common pathological changes including myelin pallor, gliosis, rarefactions, and dendritic simplification (Budka et al. 1987; Gray et al. 1992; Masliah et al. 1997; Power et al. 1993 ). Though there is accumulating evidence of primary mechanisms of neuronal injury including glutamate excitotoxicity (Dewhurst et al. 1996; Ferrarese et al. 2001; Haughey et al. 2001; Lipton 1991 ) and gp120 mediated apoptosis (Cossarizza 2008; Louboutin et al. 2007) , HIV can result in white matter pathological damage and atrophy with cognitive consequences (Cherner et al. 2007 ; Cysique et al. 2006; Heaton et al. 2004a, b; McArthur et al. 2004) . However, it is still unclear how these various pathological processes are associated with or related to cognitive dysfunction. In order to better elucidate the anatomical relationship between HIV mediated CNS injury and cognitive dysfunction, examination of HIV associated CNS injury using in vivo methods is critical.
As a method, diffusion tensor imaging (DTI) has particular utility in examining CNS white matter abnormalities in vivo. This is primarily due to the general linear organization of white matter pathways that restrict water diffusion along the length of the myelinated axonal fibers. Using the signal information from each imaging voxel, the magnitude and orientation of this water movement can be quantified and examined to provide information regarding the intrinsic structural and physiological characteristics of the underlying tissue. Given the pathological predilection of the virus for white matter and several resulting prominent white matter pathologies (i.e., myelin pallor, dendritic simplification), there have been several studies examining the utility of diffusion tensor imaging (DTI) scalar metrics probing HIV associated brain changes (Filippi et al. 2001; Pfefferbaum et al. 2007; Pomara et al. 2001; Ragin et al. 2005) . These studies consistently demonstrate alterations in the diffusion characteristics of white matter with HIV infected patients having worse fractional anisotropy (FA) and/or apparent diffusion coefficient (ADC) measures that are interpreted as an indication of white matter structural abnormalities. Fortunately, these measures are also consistently associated with alterations in cognitive domains and/or dementia status (Pfefferbaum et al. 2007; Ragin et al. 2005; Ragin et al. 2004) . These studies clearly demonstrate the utility of examining DTI scalar metrics among HIV infected patients.
However, examination of basic DTI scalar metrics utilizing a region of interest (ROI) approach ignores one of the more fascinating applications of diffusion imaging; namely DTI tractography. Tractography is a method of examining intervoxel diffusion coherence capable of producing striking images of gross white matter organization in the brain. More importantly, unlike ROI scalar metric studies, tractography makes it possible to examine diffusion characteristics along the whole length of the fiber tract. This allows researchers to avoid common pitfalls associated with ROI analyses, namely reduced variability and location of sample biases. Preliminary use of tractography metrics has benefited our understanding of white matter organization in developmental studies (typical development, autism (Assaf and Pasternak 2008; Ding et al. 2008; Dubois et al. 2008; Gilmore et al. 2007) ) and disruption of connectivity in neurological illness or injury (MS, traumatic brain injury (DeBoy et al. 2007; Schmierer et al. 2007; Wilde et al. 2008) ), as well as provide the basis for examining tracks of interest (TOIs) and their associated functional impact (schizophrenia (Schlosser et al. 2007; Skranes et al. 2007) ). These significant DTI tractography findings across a wide range of patient cohorts and the known white matter pathology associated with HIV infection suggest there is additional utility in exploring DTI tractography among HIV infected patient populations.
The purpose of this study was to examine the relationship between several recently developed and validated quantitative tractography measures (Correia et al. 2008 ) and clinical/ cognitive measures among a cohort of HIV infected patients. Specifically, we examined the relationship between several traditional tractography metrics (i.e., total length, number of tracts/streamtubes, average FA along the length of tubes), unique tractography metrics (i.e., normalized or weighted length and number of tubes), HIV disease measures (CD4 and plasma viral load), and cognitive testing with the expectation that these metrics would be significantly associated with disease burden and/or cognitive performance, especially cognitive measures typically dependent on white matter integrity (i.e., psychomotor speed, attention, and executive function). We included the examination of more specialized weighted tractography measures because, as described in the Correia et al. (2008) manuscript, these measures may be particularly sensitive to more subtle changes in white matter integrity due to inflammation and/ or other pathological processes not sufficient to produce changes in more traditional metrics. We also examine these tractography metrics for differences between HIV infected patients and demographically matched controls with the expectation that tractography results would be quantitatively altered in the context of HIV infection.
Methods
Participants Data for this study was collected as part of an NIH funded grant and all consent forms and procedures were approved by the local hospital institutional review board (IRB). In this study, we examined a sample of 23 HIV infected (33% Hepatitis C (HCV) co-infected), and 20 HCV/HIV negative controls who had diffusion tensor imaging of sufficient quality to examine (i.e., limited motion artifact). Participants were males and females representing three major ethnic groups (Caucasian, African American, and Latino). All participants were recruited from the same immunology clinic and most met criterion for alcohol and/or drug dependency as determined by the structured clinical interview (SCID). As such, all our participants had a history of alcohol/drug abuse though inclusion criterion required that they not be actively using alcohol/drugs within the past six months in order to participate. Additionally, participants were excluded from the study if they had a history of head injury with loss of consciousness greater than five minutes, learning disability, neurologic disease, active opportunistic infection, major psychiatric diagnosis, and/or MRI contraindications (i.e., metal in body). All participants underwent MRI examination using a consistent sequence protocol (see below) and standardized cognitive testing (see below). For each participant, imaging and cognitive testing were conducted within two weeks of each other. The two groups were matched at recruitment for important demographic information (age, education, drug and alcohol abuse histories; see Table 1 for summary of demographics).
Clinical diagnosis and assessment As part of routine care, each participant's plasma CD4 cell count (cells/mL) and viral load (log RNA/mL) were collected. Both CD4 cell count and viral loads were used as dependent variables in the statistical analyses. It should be noted that all HIV infected participants were required to be on stable regimens of antiretroviral treatments (ART). The participants, with one exception, had CD4 counts above 200, and the majority had low or undetectable HIV-1 RNA levels and were therefore not at significant risk for new AIDS associated conditions (see Table 1 ). The percentage of patients being treated with medication from the various classes is also illustrated in Table 1 .
Neuropsychological and neuropsychiatric evaluation All participants underwent a battery of cognitive and psychiatric testing that included both self-administered computerized and traditional neuropsychological tests. Participants were administered the IntegNeuro™□ (Brain Resource Company, Melbourne, Australia) computerized battery which contains tests of sensori-motor function, attention, executive function, language fluency, memory, and verbal intelligence estimate (see Table 2 for a list and description of tests). The reliability and validity of this battery is discussed in detail elsewhere (Paul et al. 2005; Silverstein et al. 2007 ). Raw testing data was converted to a standardized z-score using normative data from the IntegNeuro™□ international database. Scores are normalized for age, gender, and education.
We also added two more traditional neuropsychological tests including the Wechsler Adult Intelligence Scale-3rd Edition symbol digits (SD) subtest and the grooved pegboard test from the Reitan battery. Raw testing data was converted to z-scores using the Heaton norms (Heaton et al. 2004a, b) , which control for age, education, and gender. Additionally, each participant was administered a measure of depression (The Beck Depression Inventory (BDI)) and a self-assessment of alcohol/drug dependency (The Kreek-McHugh-Schluger-Kellog Scale (KMSK)). Importantly, we used the KMSK to match the experimental groups for alcohol/drug dependency histories. This selfreport questionnaire quantifies amount, frequency, and duration of alcohol, heroin, and cocaine use separately. Scores range from 0 to 15 with scores greater than or equal to nine (heroin) and 11 (alcohol and cocaine) indicating a likely diagnosis of dependency (Kellogg et al. 2003) . Scores for the BDI and KMSK are seen in Table 1 for each experimental group.
MRI methods All participants underwent MRI (Siemens 1.5T Symphony, Siemens, Germany) utilizing a standard imaging protocol that included a diffusion tensor imaging (DTI) sequence. The Siemens MDDW protocol was used to collect a series of three co-registered sagittal double-spinecho, diffusion-weighted echo-planar volumes. The following parameters were used to consistently acquire DTI data from all participants: 5 mm thick slices, 0.1 mm inter-slice spacing, 30 slices per acquisition, matrix=128×128, FOV= 21.7×21.7 cm, TR=7,200, TE=156, no partial echoes, NEX=3. Diffusion encoding gradients (b=0, 1,000 mm/s 2 ) were applied in 12 non-collinear directions. Each subsequent series acquisition (in the series of three) was spatially offset in the slice direction by 1.7 mm. Total time for the three acquisitions was slightly less than 15 min. Using a post-processing routine, the three acquisitions were then interleaved to achieve 1.7 mm 3 resolution images and upsampled (equivalent to zero-filling) to 0.85 mm 3 isotropic voxels for analysis. From these images, we calculated the eigen-values and eigen-vectors at each voxel to derive fractional anisotropy (FA) and diffusivity (ADC) maps.
Streamtube tractography map generation and tractography metrics of interest Tractography maps were generated for each participant using custom in house software. Briefly, streamtube models of cerebral white matter were based on the major eigenvector of the diffusion tensor field and created using a dense seeding and culling approach detailed in the Zhang et al. (2003) paper. This approach uses a dense seeding criterion (seeds placed every 0.85 mm 3 ) and specifies optimal input parameters for tube generation (i.e., minimum threshold for linear anisotropy=0.1, minimum tube length=10 mm, minimum distance between tubes=2 voxels, and integration step size=1 mm). Combined, the seeding and parameter settings minimize the number of anatomically implausible fibers in regions of low anisotropy (i.e., CSF, muscle) while retaining linear structures in most of the brain parenchyma. The initial pass produces a dense set of streamtubes that are then subjected to an automated distance-based culling process that removes similar (i.e., redundant) streamtubes to facilitate visual inspection and quantitative analysis.
Basic measures of interest generated by the outcome include the total number of streamtubes generated, the total length of these tubes, the length of the stream tubes normalized by FA, and the average tractography FA for the total white matter model. These are described in detail in the recent published manuscript (Correia et al. 2008) . In this paper, we examined five tractography metrics including global fractional anisotropy (FA), normalized number of tubes, average length of tubes, normalized total length of tubes, and the normalized weighted length of tubes (see Table 3 for a brief description of each measure). Additionally, as described in the Correia et al. paper (2008) , the number of tubes and length of tubes metrics were scaled by a factor accounting for head size using the following formula: tractography metric divided by the ratio of each person's intracranial volume divided by the average intracranial volume for the entire group. This was an attempt to account for any potential differences in head size given the fact that our sample included male and female participants with potentially disparate head sizes. We used the structural imaging variable for total intracranial contents as a measure of head size for each of the participants. This was derived using the automated structural imaging pipeline processing software package FreeSurfer (MGH, Boston, MA) which uses the T1 MPRAGE volumetric sequences to extract, segment, parcellate, and measure brain tissue. After visual inspection and manual edits (when needed) of the FreeSurfer output, the intracranial contents (i.e., brain parenchyma, ventricular space, and surface/pial CSF) measure was recorded and used as the head size variable.
Statistics Examination of the data included both visual and quantitative inspection of the data for normalcy. Tractography measures appeared to be normally distributed though as might be expected, plasma viral loads were not. For this reason, viral loads were divided into undetectable (≤75) and detectable (>75) groups for analysis.
The tractography metrics for the two groups were compared using independent t-tests with the metrics as the dependent variables and the diagnostic group as the grouping variable. We also examined the association between the global tractography metrics and cognitive performance within domains using correlation analyses.
We then compared the magnitude of the significant associations between the two groups using Fisher's z-transformation test. Among the HIV infected patients, we also examined the relationship between the tractography metrics and measures of disease severity including CD4 counts and viral loads using parametric (CD4 values) and non-parametric (viral loads) correlation analysis. In a set of secondary post-hoc analyses, we examined the differences between the HIV mono-infected (n=17) and HIV/HCV coinfected (n=6) patients using an independent t-test.
Results
Demographic variables As expected (due to matching), the two groups did not differ with respect to age, education, gender or ethnicity, BDI scores, or alcohol, cocaine, or heroin dependency histories (see Table 1 ). Given the similarities between the two groups, no statistical adjustments were made to the group comparisons or the correlational analyses.
Quantitative tractography results Visualization of the means for each of the tractography measures indicated reductions in all the tractography measures except the normalized number of tubes which appears to be relatively similar between the groups (See Fig. 1 ). However, these differences in means were not statistically significant for any comparison except for a difference in global tractography FA (t=2.13, p=0.04). Effect sizes calculated using the means and standard deviations suggest small effect sizes for the average tube length (Cohen's d=0.30) and normalized total number of tubes (Cohen's d=0.33), medium effect sizes for FA weighted tube length (Cohen's d=0.42) and normalized length of tubes (Cohen's d=0.55), and a large effect size for the global tractography FA (Cohen's d=0.81).
Clinical relationships For the HIV infected patient cohort, plasma CD4 counts were inversely associated with the normalized number of tubes (r=−0.43, p=0.02; i.e., the number of tubes increased as CD4 cell counts declined). No other significant associations were found for any measure (r-value range 0.01 to 0.43 for CD4 and 0.18 to 0.32 for viral load).
Cognitive relationships The association between global tractography metrics and cognitive performance for each domain were examined for each experimental group separately (See Tables 4 and 5 ). When examining the associations between tractography measures and cognition among the HIV negative patients fewer overall significant associations are demonstrated and the direction of the association is not always as expected (i.e., average tube length is often negatively correlated with cognitive performance). Significant relationships included a positive association between switching 1 (similar to Trails A) and global tractography FA (r=0.65, p<0.001) and the time to complete the mazes task was related to all but one of the tractography measures (r range was 0.55 to 0.73). Another association was found between the normalized number of tubes and the grooved pegs dominant hand performance (r=−0.52, p=0.03). However, after adjusting for multiple comparisons (0.05/number of comparison), only two of the six significant relationships remained (global tractography FA and switching 1; weighted tube length and time to maze completion). For the HIV infected patient group, the number of relationships was greater than that of controls. The most consistently robust imaging measure appeared between the FA weighted tube length and cognitive measures as it was associated with eight of the 12 cognitive tests examined. Even when adjusting the significance level for multiple comparisons (0.05/number of comparison) half of the significant associations remained significant. Global tractography FA values also appear to be associated with a significant number of tests including tapping rates, switching 1 and 2, verbal interference, and mazes (r-value range 0.42 to 0.69). Tapping rates with the dominant hand was positively associated with all but one of the tractography measures (not related to normalized number of tubes, r=−0.19, p=0.20) with r-values ranging from of 0.39 to 0.53 (15 to 28% of the variance). Consistently, the associations between the tractography metrics and cognitive performance were such that worse tractography values indicated poorer cognitive performance. For example, the time it took to complete switching 1 and 2 tasks (adaptations of Trails A and B) increased with reduction in global FA, average tube length, normalized total tube length, normalized weighted tube length while the number of taps with the dominant hand in a set period of time was increased with increased global FA, average tube length, normalized total tube length, and normalized weighted tube length (see Table 5 ). Direct comparison of the significant correlation coefficients between the groups using Fisher's z-transformation demonstrated only three significantly different correlation coefficients (tapping, switching A, and switching B for the FA weighted tube length measure) where the magnitude of the correlation coefficient for the HIV positive patients exceeded the controls. There was a single significant Fishers z-transformation for the mazes and normalized number of tubes where the control correlation coefficient exceeded that of the HIV positive patients.
Secondary analysis of HCV/HIV coinfection In a set of secondary post-hoc analyses, we compared the tractography measures for the 17 HIV mono-infected patients with the 6 HIV/HCV co-infected patients as there has been both clinical and cognitive evidence of increased neurological risk associated with HCV co-infection. Results from these preliminary comparisons revealed no significant differences although the average length of tubes measure appeared to be trending toward a significant difference (t=−2.03, p= 0.057) where the co-infected patients demonstrated a smaller average tube length. No significant differences were noted between the measures of global FA, normalized number of tubes, normalized total tube length, and normalized weighted tube length between the two groups. 
Discussion
The most significant finding for this study was the number and magnitude of correlations noted between the tractography metrics and cognitive performance among the HIV infected patients. To our knowledge, this is the first study to examine global tractography metrics and a broad range of cognitive function in HIV infected patients. The overall tube length weighted by FA appeared to be most consistently related to the cognitive performance even when correcting for multiple comparisons. However, global tractography FA was also related to many cognitive tests. The weighted tube length measure is a unique measure to our group and is described in more detail in the recent Correia et al. (2008) paper. As stated in that paper, this metric might be more sensitive to subtle changes in FA where the change in FA is too small to negatively impact tube generation, yet is still reduced in the disease state. This is clearly happening in this population as the global FA value is significantly reduced in the HIV positive patients relative to the controls. However, other important associations were observed with motor tapping rates, measures of processing speed, and executive function, all aspects of cognition that are highly dependent on white matter integrity. We believe these results indicate that tractography metrics capture information regarding cognitive performance and that with further validation these metrics might be used to improve treatment recommendations and/or improve our ability to determine the progression and evolution of CNS injury in HIV infection within the white matter. However, there is still much to be learned about the pathological correlates of DTI. This fact limits the number of inferences that can positively be made though it is clear that these measures capture cognitively important structural aspects of the CNS in the context of HIV infection and that these methods warrant further examination.
We also demonstrated a significant association between the normalized number of streamtubes and CD4 counts for HIV infected patients. The inverse association suggests that with declining CD4 counts, the overall number of streamtubes generated increases. This finding could be an indication of small, localized variations in the anisotropy that exceed acceptable parameters resulting in "broken" tracts or fragmentation of tracts. However, the significance of this single association should not be overstated due to the small sample size and number of comparisons being made.
As such, this finding should be examined in the context of larger and/or prospective studies examining the evolution and progression of these tractography abnormalities. Attempts to find differences between the HIV infected and HIV negative patients revealed a significant difference for global tractography FA, but not for any of the other tractography metrics. Global and regional changes in FA have been reported in HIV infected patients since diffusion imaging was first used by Fillipi et al. (2001) . For example, FA has been shown to be reduced in several ROI studies, especially in the different regions of the corpus callosum of HIV infected patients. Additionally, using tractography metrics to examine regional corpus callosum (not global tractography) differences in HIV infected patients, Pfefferbaum et al. (2007) conclude that FA was reduced in the genu and splenium of the corpus callosum.
It should be pointed out, that our sample is unique to other studies in that we matched experimental groups by drug (cocaine and heroine) and alcohol histories. Controlling for drug and alcohol use is important in HIV given the relatively high prevalence of use (Haverkos 1998; Samet et al. 2007 ) and the well-established neurologic risk associated with use among HIV infected patients (Pfefferbaum et al. 2007 ). The significant difference in global tractography FA in this study suggests that this difference is related to HIV infection. Overall, the metrics were clearly reduced in HIV infected patients (see Fig. 1 ). The lack of significance may be due to sample size as an examination of the differences between the means suggest small effect sizes for the number of tubes and average tube length (Cohen's d=0.30 and 0.33 respectively) and medium effect sizes for weighted length of tubes and normalized length of tubes (Cohen's d=0.42 and 0.55 respectively).
Additionally, visualization of the tractography models suggests the need for further examination at a regional level for differences, as there were noticeable qualitative differences between HIV positive patient and HIV negative control groups (see Fig. 2 ). For example, it appears that there are visually apparent reductions in the number of tubes generated in the frontal, subcortical, and cerebellar regions for the HIV infected patients. These are interesting qualitative observations given the fact that we know there is a pathological predilection of the virus for the frontal/subcortical regions of the brain (Budka et al. 1987; Everall et al. 1993) and that there may be a reason for more disorganization of white matter in these areas. However, when examining the tractography results on a global level, we did not find differences in the tube model metrics though the lack of significance may be attributed to more subtle regional differences that are obscured when examining whole brain measures. Future studies of tractography metrics might be improved by examining regional differences or possibly by examining specific white matter fiber bundles or fasciculi. For example, comparing tractography metrics from the frontal white matter (frontal forceps), motor tract through the internal capsule, and/or frontal subcortical connections may contain more HIV relevant information. The issue of HIV/HCV co-infection is extremely important for American and European cohorts where the rates of co-infection are as high as 30 percent (Perry et al. 2008 ). Our small sample included approximately 30 percent HIV/HCV co-infected patients and as a group should be relatively representative of the general HIV population commonly observed in the United States. This small number of subjects only allowed for a preliminary examination of the HIV/HCV co-infection status. However, given the evidence of worsening cognitive function associated with co-infection status (Everall et al. 2005; von Giesen et al. 2004; Cherner et al. 2005; Hilsabeck et al. 2005) as well as negative affects on the course of HIV infection and/or risk of death due to HCV/liver related illnesses (Kim and Lauer 2007; Lin et al. 2008; Smit et al. 2008; Sulkowski et al. 2007 ) we examined our HIV infected patients for differences in tractography measures between mono-and co-infected patients. In this preliminary post-hoc analyses, HIV/HCV comparisons revealed no significant differences between the two groups for any of the global tractography measures though the average tube length appeared to be trending toward a significant difference with the coinfected group having the smaller average tube length. Additional studies examining the brain using in vivo brain imaging for findings associated with HIV/HCV co-infection are still needed.
There are several limitations to this study. First, the number of patient participants was limited. The small number of participants limits the power of the study and the inferences that we can make regarding the findings especially when making so many statistical comparisons. It will be important to replicate these findings in larger studies. Additionally, the cross sectional nature of this study is also another potential limitation. Though it is clear from the data that there are significant associations between these tractography measures and cognitive performance (especially for the HIV infected patients), understanding the causal or the temporal nature of the relationships is obscured. Given the fact that validity and reliability of the tractography measures were demonstrated to be quite robust (Correia et al. 2008) , tractography methods might be used to examine change associated with HIV infection.
Additionally, there are methodological caveats that should be considered when interpreting these findings (for more detail see the Correia et al. 2008 manuscript) . For example, the generation of tractography maps relies on several somewhat arbitrarily determined parameters including FA and length thresholds. For this particular study, thresholds were selected based on our experience with this particular data set and visual inspection of the data that minimize the number of spurious otherwise anatomically implausible tracts (issue of validity). This is important to remember because the underlying assumption is that HIV infection alters the generation of these tractography models so as to reduce the number and length of tubes generated. However, as mentioned in the Correia et al. (2008) manuscript, utilizing different threshold for these parameters did not affect the pattern of results in a repeated study of the same patient cohort. Subject motion is always a concern in DTI tractography as streamtube models can be negatively impacted by motion. This is a particular concern with our data because it relies on the interleaving of three five minute scans to derive the final FA maps. Recognizing this potential limitation, a vacuum pillow was used during the scan session to minimize motion. Patients and controls were also extensively coached before and during scan acquisition.
HIV+ Participant
HIV-Participant Fig. 2 Illustration of the tractography output for HIV negative control participant and HIV infected patient. Qualitative differences are identified by the red arrows and circles Qualitatively, this resulted in a relatively clean usable data set and we only excluded three imaging data sets due to excessive motion artifacts. Though correcting for motion might improve the reliability of the streamtube generation, there is no consensus for an optimal method described in the literature at this time and no motion correction was used in this data.
It is clear that there is still much to learn about white matter change in HIV infected patients. Given the results of this paper, we expect that DTI tractography as a method holds much promise in examining and delineating pathological changes associated with HIV infection. Additionally, the robust associations of DTI tractography metrics with cognitive testing may be an indication of the general clinical utility of such measures and should be investigated more thoroughly in larger prospective studies.
